101 related articles for article (PubMed ID: 28471204)
1. [Diagnostic and Therapeutic Potential of Membrane HSP90].
Vacek O; Pastorek M; Durech M; Vojtěšek B; Müller P
Klin Onkol; 2017; 30(Supplementum1):191-194. PubMed ID: 28471204
[TBL] [Abstract][Full Text] [Related]
2. [Impact of HSP90 Inhibition on Viability and Cell Cycle in Relation to p53 Status].
Pastorek M; Müller P; Vojtěšek B
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):40-45. PubMed ID: 27846719
[TBL] [Abstract][Full Text] [Related]
3. The Role of HSP70 in Cancer and its Exploitation as a Therapeutic Target.
Martinková V; Trčka F; Vojtěšek B; Müller P
Klin Onkol; 2018; 31(Suppl 2):46-54. PubMed ID: 31023024
[TBL] [Abstract][Full Text] [Related]
4. The Role of HSF1 Protein in Malignant Transformation.
Šimončík O; Pastorek M; Vojtěšek B; Müller P
Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
[TBL] [Abstract][Full Text] [Related]
5. [Endoplasmic Reticulum Chaperones at the Tumor Cell Surface and in the Extracellular Space].
Brychtová V; Vojtěšek B
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):25-30. PubMed ID: 27846717
[TBL] [Abstract][Full Text] [Related]
6. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of Protein Homeostasis Regulation in Cancer Development].
Trčka F; Müller P; Vojtěšek B
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):18-24. PubMed ID: 27846716
[TBL] [Abstract][Full Text] [Related]
8. Expression and Functional Characterization of miR-34c in Cervical Cancer.
Sommerová L; Fraňková H; Anton M; Jandáková E; Vojtěšek B; Hrstka R
Klin Onkol; 2018; 31(Suppl 2):82-87. PubMed ID: 31023029
[TBL] [Abstract][Full Text] [Related]
9. [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
Li X; Deng HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):181-3. PubMed ID: 18630678
[TBL] [Abstract][Full Text] [Related]
10. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
Lee CH; Hong HM; Chang YY; Chang WW
Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
[TBL] [Abstract][Full Text] [Related]
12. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study.
Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L
Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
14. Possible Usage of p63 in Bioptic Diagnostics.
Galoczová M; Nenutil R; Coates P; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
16. Associations of HSP90 client proteins in human breast cancer.
Shipp C; Watson K; Jones GL
Anticancer Res; 2011 Jun; 31(6):2095-101. PubMed ID: 21737627
[TBL] [Abstract][Full Text] [Related]
17. HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion.
Taiyab A; Rao ChM
Biochim Biophys Acta; 2011 Jan; 1813(1):213-21. PubMed ID: 20883729
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition.
Pastorek M; Muller P; Coates PJ; Vojtesek B
PLoS One; 2018; 13(8):e0202758. PubMed ID: 30138434
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
Koga F; Kihara K; Neckers L
Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
